$node = stdClass Object (
[nid] => [9958]
[vid] => [10016]
[type] => [center_people]
[status] => [1]
[created] => [1224505068]
[changed] => [1246898681]
[comment] => [2]
[promote] => [0]
[sticky] => [0]
[revision_timestamp] => [1246898681]
[title] => [Stuart J. Frank, M.D.]
[body] => [<div class="field field-type-image field-field-people-image"><div class="field-label">People Image: </div><div class="field-items"><div class="field-item"><img src="http://www.diabetescenters.org/files/sfrank.jpg" alt="sfrank.jpg" title="sfrank.jpg" width="100" height="140" /></div></div></div><div class="field field-type-text field-field-center-name"><div class="field-label">Center Name: </div><div class="field-items"><div class="field-item">DRTC - University of Alabama at Birmingham</div></div></div><div class="field field-type-text field-field-core"><div class="field-label">Core List: </div><div class="field-items"><div class="field-item">DRTC UAB Administrative Core</div></div></div><div class="field field-type-text field-field-phone-number"><div class="field-label">Phone Number: </div><div class="field-items"><div class="field-item">205-934-9877</div></div></div><div class="field field-type-text field-field-people-details"><div class="field-label">People Details: </div><div class="field-items"><div class="field-item"><p><strong>Research Interests:</strong></p>
<p> The focus of research in my laboratory is understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. In particular, I am interested in various aspects of GH receptor (GHR) structure and signal transduction. Our studies have examined the interaction of the GHR with a critical non-receptor cytoplasmic tyrosine kinase, JAK2, which is required for initiation of GHR signaling. We have explored the downstream signaling pathways (STAT, MAP kinase, and PI-3 kinase) activated by GH and their effects on GH-induced gene expression.</p>
<p>Our current interests surround several aspects of the actions of GH and prolactin. Specifically, we are intensely investigating: 1) molecular studies of mechanisms of GH-induced activation of the JAK2 tyrosine kinase; 2) the cellular determinants of sensitivity to GH and modulation of GHR availability and function; 3) inducible GHR metalloproteolysis as a mechanism of generation of the GH binding protein (GHBP) and as a regulator of in vivo hepatic GH sensitivity; 4) mechanisms of GH action in bone and muscle; 5) crosstalk between the GH and epidermal growth factor (EGF) signaling pathways, between the GH and insulin-like growth factor-1 (IGF-1) signaling pathways, and between the PRL and EGF signaling pathways.</p>
<p> </p>
<p><a href="http://endo.dom.uab.edu/faculty/sfrank/">More</a></p>
</div></div></div><div class="field field-type-text field-field-center-title"><div class="field-label">center_title: </div><div class="field-items"><div class="field-item">Associate Center Director and Director, DRTC Pilot and Feasibility Program</div></div></div>]
[log] => []
[format] => [0]
[uid] => [236]
[name] => [stuart.frank]
[picture] => []
[data] => [a:0:{}]
[path] => [people/stuart-j-frank-md]
[nodewords] => []
[last_comment_timestamp] => [1224505068]
[last_comment_name] => []
[comment_count] => [0]
[taxonomy] => []
[files] => []
[field_people_image] => array (
[0] => array (
[fid] => [170]
[title] => [sfrank.jpg]
[alt] => [sfrank.jpg]
[nid] => [9958]
[filename] => [sfrank.jpg]
[filepath] => [files/sfrank.jpg]
[filemime] => [image/jpeg]
[filesize] => [31816]
[view] => [<img src="http://www.diabetescenters.org/files/sfrank.jpg" alt="sfrank.jpg" title="sfrank.jpg" width="100" height="140" />]
)
)
[field_center_name] => array (
[0] => array (
[value] => [2538]
[view] => [DRTC - University of Alabama at Birmingham]
)
)
[field_core] => array (
[0] => array (
[value] => [10012]
[view] => [DRTC UAB Administrative Core]
)
)
[field_center_title] => array (
[0] => array (
[value] => [Associate Center Director and Director, DRTC Pilot and Feasibility Program]
[view] => [Associate Center Director and Director, DRTC Pilot and Feasibility Program]
)
)
[field_people_details] => array (
[0] => array (
[value] => [<p><strong>Research Interests:</strong></p><p><br /> The focus of research in my laboratory is understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. In particular, I am interested in various aspects of GH receptor (GHR) structure and signal transduction. Our studies have examined the interaction of the GHR with a critical non-receptor cytoplasmic tyrosine kinase, JAK2, which is required for initiation of GHR signaling. We have explored the downstream signaling pathways (STAT, MAP kinase, and PI-3 kinase) activated by GH and their effects on GH-induced gene expression.</p> <p>Our current interests surround several aspects of the actions of GH and prolactin. Specifically, we are intensely investigating: 1) molecular studies of mechanisms of GH-induced activation of the JAK2 tyrosine kinase; 2) the cellular determinants of sensitivity to GH and modulation of GHR availability and function; 3) inducible GHR metalloproteolysis as a mechanism of generation of the GH binding protein (GHBP) and as a regulator of in vivo hepatic GH sensitivity; 4) mechanisms of GH action in bone and muscle; 5) crosstalk between the GH and epidermal growth factor (EGF) signaling pathways, between the GH and insulin-like growth factor-1 (IGF-1) signaling pathways, and between the PRL and EGF signaling pathways.</p><p> </p><p><a href="http://endo.dom.uab.edu/faculty/sfrank/">More</a></p>]
[format] => [1]
[view] => [<p><strong>Research Interests:</strong></p>
<p> The focus of research in my laboratory is understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. In particular, I am interested in various aspects of GH receptor (GHR) structure and signal transduction. Our studies have examined the interaction of the GHR with a critical non-receptor cytoplasmic tyrosine kinase, JAK2, which is required for initiation of GHR signaling. We have explored the downstream signaling pathways (STAT, MAP kinase, and PI-3 kinase) activated by GH and their effects on GH-induced gene expression.</p>
<p>Our current interests surround several aspects of the actions of GH and prolactin. Specifically, we are intensely investigating: 1) molecular studies of mechanisms of GH-induced activation of the JAK2 tyrosine kinase; 2) the cellular determinants of sensitivity to GH and modulation of GHR availability and function; 3) inducible GHR metalloproteolysis as a mechanism of generation of the GH binding protein (GHBP) and as a regulator of in vivo hepatic GH sensitivity; 4) mechanisms of GH action in bone and muscle; 5) crosstalk between the GH and epidermal growth factor (EGF) signaling pathways, between the GH and insulin-like growth factor-1 (IGF-1) signaling pathways, and between the PRL and EGF signaling pathways.</p>
<p> </p>
<p><a href="http://endo.dom.uab.edu/faculty/sfrank/">More</a></p>
]
)
)
[field_phone_number] => array (
[0] => array (
[value] => [205-934-9877]
[view] => [205-934-9877]
)
)
[field_address] => array (
[0] => array (
[value] => []
[view] => []
)
)
[page_title] => []
[readmore] => []
[content] => array (
[field_people_image] => array (
[#access] => [1]
[#value] => [<div class="field field-type-image field-field-people-image"><div class="field-label">People Image: </div><div class="field-items"><div class="field-item"><img src="http://www.diabetescenters.org/files/sfrank.jpg" alt="sfrank.jpg" title="sfrank.jpg" width="100" height="140" /></div></div></div>]
[#weight] => [-4]
[#printed] => [1]
)
[field_center_name] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-center-name"><div class="field-label">Center Name: </div><div class="field-items"><div class="field-item">DRTC - University of Alabama at Birmingham</div></div></div>]
[#weight] => [-3]
[#printed] => [1]
)
[field_core] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-core"><div class="field-label">Core List: </div><div class="field-items"><div class="field-item">DRTC UAB Administrative Core</div></div></div>]
[#weight] => [-2]
[#printed] => [1]
)
[field_phone_number] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-phone-number"><div class="field-label">Phone Number: </div><div class="field-items"><div class="field-item">205-934-9877</div></div></div>]
[#weight] => [0]
[#printed] => [1]
)
[body] => array (
[#weight] => [0]
[#value] => []
[#printed] => [1]
)
[field_people_details] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-people-details"><div class="field-label">People Details: </div><div class="field-items"><div class="field-item"><p><strong>Research Interests:</strong></p>
<p> The focus of research in my laboratory is understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. In particular, I am interested in various aspects of GH receptor (GHR) structure and signal transduction. Our studies have examined the interaction of the GHR with a critical non-receptor cytoplasmic tyrosine kinase, JAK2, which is required for initiation of GHR signaling. We have explored the downstream signaling pathways (STAT, MAP kinase, and PI-3 kinase) activated by GH and their effects on GH-induced gene expression.</p>
<p>Our current interests surround several aspects of the actions of GH and prolactin. Specifically, we are intensely investigating: 1) molecular studies of mechanisms of GH-induced activation of the JAK2 tyrosine kinase; 2) the cellular determinants of sensitivity to GH and modulation of GHR availability and function; 3) inducible GHR metalloproteolysis as a mechanism of generation of the GH binding protein (GHBP) and as a regulator of in vivo hepatic GH sensitivity; 4) mechanisms of GH action in bone and muscle; 5) crosstalk between the GH and epidermal growth factor (EGF) signaling pathways, between the GH and insulin-like growth factor-1 (IGF-1) signaling pathways, and between the PRL and EGF signaling pathways.</p>
<p> </p>
<p><a href="http://endo.dom.uab.edu/faculty/sfrank/">More</a></p>
</div></div></div>]
[#weight] => [0]
[#printed] => [1]
)
[field_center_title] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-center-title"><div class="field-label">center_title: </div><div class="field-items"><div class="field-item">Associate Center Director and Director, DRTC Pilot and Feasibility Program</div></div></div>]
[#weight] => [0]
[#printed] => [1]
)
[field_address] => array (
[#access] => [1]
[#value] => []
[#weight] => [1]
[#printed] => [1]
)
[#children] => [<div class="field field-type-image field-field-people-image"><div class="field-label">People Image: </div><div class="field-items"><div class="field-item"><img src="http://www.diabetescenters.org/files/sfrank.jpg" alt="sfrank.jpg" title="sfrank.jpg" width="100" height="140" /></div></div></div><div class="field field-type-text field-field-center-name"><div class="field-label">Center Name: </div><div class="field-items"><div class="field-item">DRTC - University of Alabama at Birmingham</div></div></div><div class="field field-type-text field-field-core"><div class="field-label">Core List: </div><div class="field-items"><div class="field-item">DRTC UAB Administrative Core</div></div></div><div class="field field-type-text field-field-phone-number"><div class="field-label">Phone Number: </div><div class="field-items"><div class="field-item">205-934-9877</div></div></div><div class="field field-type-text field-field-people-details"><div class="field-label">People Details: </div><div class="field-items"><div class="field-item"><p><strong>Research Interests:</strong></p>
<p> The focus of research in my laboratory is understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. In particular, I am interested in various aspects of GH receptor (GHR) structure and signal transduction. Our studies have examined the interaction of the GHR with a critical non-receptor cytoplasmic tyrosine kinase, JAK2, which is required for initiation of GHR signaling. We have explored the downstream signaling pathways (STAT, MAP kinase, and PI-3 kinase) activated by GH and their effects on GH-induced gene expression.</p>
<p>Our current interests surround several aspects of the actions of GH and prolactin. Specifically, we are intensely investigating: 1) molecular studies of mechanisms of GH-induced activation of the JAK2 tyrosine kinase; 2) the cellular determinants of sensitivity to GH and modulation of GHR availability and function; 3) inducible GHR metalloproteolysis as a mechanism of generation of the GH binding protein (GHBP) and as a regulator of in vivo hepatic GH sensitivity; 4) mechanisms of GH action in bone and muscle; 5) crosstalk between the GH and epidermal growth factor (EGF) signaling pathways, between the GH and insulin-like growth factor-1 (IGF-1) signaling pathways, and between the PRL and EGF signaling pathways.</p>
<p> </p>
<p><a href="http://endo.dom.uab.edu/faculty/sfrank/">More</a></p>
</div></div></div><div class="field field-type-text field-field-center-title"><div class="field-label">center_title: </div><div class="field-items"><div class="field-item">Associate Center Director and Director, DRTC Pilot and Feasibility Program</div></div></div>]
[#printed] => [1]
)
[links] => array (
[comment_forbidden] => array (
[title] => [<a href="/user/login?destination=comment/reply/9958%2523comment-form">Login</a> to post comments]
[html] => [1]
)
)
);